Giant Biogene Holding Co. Ltd.'s market cap is currently HK$61.57B. The company's EPS TTM is HK$1.946; its P/E ratio is 31.11; and it has a dividend yield of 0.79%. Giant Biogene Holding Co. Ltd. is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is HK$1.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 3.52B	¥ 2.36B	¥ 1.55B	¥ 1.19B	¥ 956.70M
Gross Profit	¥ 2.95B	¥ 2.00B	¥ 1.35B	¥ 1.01B	¥ 796.71M
Operating Income	¥ 1.66B	¥ 1.19B	¥ 914.57M	¥ 651.81M	¥ 688.64M
EBITDA	¥ 1.78B	¥ 1.21B	¥ 938.78M	¥ 674.10M	¥ 706.53M
Net Income	¥ 1.45B	¥ 1.00B	¥ 828.13M	¥ 826.45M	¥ 552.26M
Balance Sheet
Cash & Short-Term Investments	¥ 3.78B	¥ 2.20B	¥ 7.26B	¥ 1.96B	¥ 818.95M
Total Assets	¥ 4.97B	¥ 3.14B	¥ 7.88B	¥ 2.65B	¥ 1.80B
Total Debt	¥ 2.73M	¥ 2.59M	¥ 0.00	¥ 0.00	¥ 0.00
Net Debt	¥ -2.50B	¥ -1.33B	¥ -7.10B	¥ -367.81M	¥ -72.32M
Total Liabilities	¥ 602.03M	¥ 301.19M	¥ 6.86B	¥ 2.19B	¥ 645.49M
Stockholders' Equity	¥ 4.36B	¥ 2.83B	¥ 1.02B	¥ 458.00M	¥ 1.15B
Cash Flow
Free Cash Flow	¥ 1.42B	¥ 778.39M	¥ 581.21M	¥ 757.79M	¥ 541.55M
Operating Cash Flow	¥ 1.65B	¥ 931.64M	¥ 692.40M	¥ 834.12M	¥ 656.46M
Investing Cash Flow	¥ -527.28M	¥ -858.74M	¥ 1.56B	¥ -521.12M	¥ -589.85M
Financing Cash Flow	¥ 51.81M	¥ -5.79B	¥ 4.48B	¥ -17.52M	¥ -2.16M

Currency in CNY

Giant Biogene Holding Co. Ltd. Earnings and Revenue History

Income Statement >

Giant Biogene Holding Co. Ltd. Debt to Assets

Balance Sheet >

Giant Biogene Holding Co. Ltd. Cash Flow

Cash Flow >

Giant Biogene Holding Co. Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing